Human monoclonal antibody cures Marburg, Ravn infections in monkeys | Learn more about the benefits of research involving nonhuman primates | Collaboration may yield treatments for cancers in humans, dogs
April 12, 2017
FBR Smartbrief
SIGN UP ⋅   FORWARD
Top Story
Human monoclonal antibody cures Marburg, Ravn infections in monkeys
Treatment with a monoclonal antibody isolated from the blood of a woman who survived a Marburg virus infection cured Marburg as well as Ravn virus infections in monkeys, researchers reported in Science Translational Medicine. The NIH and the HHS Biomedical Advanced Research and Development Authority provided funding for the research, and scientists are now studying methods for producing large quantities of the antibody and testing it in humans.
NBC News (4/8) 
LinkedIn Twitter Facebook Google+ Email
Learn more about the benefits of research involving nonhuman primates
To get FBR's white paper and brochure, "The Critical Role of Nonhuman Primates in Medical Research" and "Lifesaving Benefits of Primate Research", go to monkeyresearch.org.
LinkedIn Twitter Facebook Google+ Email
Research Breakthroughs
Collaboration may yield treatments for cancers in humans, dogs
Collaboration may yield treatments for human, canine cancers.
(Pixabay)
Researchers at Children's Mercy Hospital in Kansas City, Mo., are working with animal health scientists to see whether a canine osteosarcoma drug works against glioblastoma in children. The researchers plan to apply for permission to conduct a Phase II clinical trial based on the drug's safety profile in dogs, and they are working with area universities to set up an electronic database for sharing data from animal and human trials.
The Kansas City Star (Mo.) (4/10) 
LinkedIn Twitter Facebook Google+ Email
 
Hamster from China carries legacy of innovative drugs
Cricetulus griseus, a hamster endemic to China's northern deserts, has been important to medical research since the early 1900s because of the ease with which its cells -- particularly ovarian cells -- can be cultured and genetically modified. At least six top-selling biologic drugs, including the world's first biologic, are derived from lab-grown cell lines that originated in the species.
The Wall Street Journal (tiered subscription model) (4/10) 
LinkedIn Twitter Facebook Google+ Email
Researchers cast nets far and wide in search for cures
Researchers cast nets far and wide in search for cures.
(Pixabay)
Biomedical researchers collect an assortment of samples in their search for cures, including cannibalistic cone snails, dirt, horseshoe crabs, feces and reptile venom. "We don't know what the role of one little fish or one little snake is unless we research every single thing on the planet," said Kristen Wiley, co-director of the Kentucky Reptile Zoo.
STAT (tiered subscription model) (4/11) 
LinkedIn Twitter Facebook Google+ Email
 
Genetically engineered mouse might predict the next influenza pandemic
A newly developed transgenic mouse might help scientists predict whether a given influenza virus strain can evade the human immune protein MxA and thus has the potential to cause a global pandemic. The mice express human MxA instead of murine MxA and can distinguish between MxA-sensitive influenza virus strains and strains that can evade MxA, the scientists reported in the Journal of Experimental Medicine.
United Press International (4/10) 
LinkedIn Twitter Facebook Google+ Email
Ultrasound technique shows promise for Alzheimer's in mouse study
Researchers at the Queensland Brain Institute report in the journal Brain that they used ultrasound to deliver therapeutic antibodies to the brain, slowing the progression of Alzheimer's disease in mice. Ultrasound safely opened the blood-brain barrier enough to allow the delivery of an antibody that binds to tau proteins, and the researchers hope the technique can eventually be used to treat other neurological conditions, such as Parkinson's disease.
The Guardian (London)/Australian Associated Press (4/4) 
LinkedIn Twitter Facebook Google+ Email
Other News
Animal Health
Veterinarian sees solutions in comparative medicine
Clemson University veterinarian John Parrish examines mice, rats, sheep, horses and cows on any given day, and his background in comparative medicine reflects his interest in supporting human health, too. In his work with nonhuman primates, Parrish has seen firsthand the role of animals in research and the bonds caregivers form with research animals, whose well-being depends on patience and experience.
Independent Mail (Anderson, S.C.) (4/12) 
LinkedIn Twitter Facebook Google+ Email
Other News
Policy News
FDA signs R&D agreement with organ-on-a-chip maker
The FDA signed a cooperative research and development agreement with Wyss Institute spinoff Emulate to create a toxicity testing platform based on the company's organ-on-a-chip technology. The collaboration might eventually reduce the number of animals needed for preclinical testing.
Endpoints News (4/11),  Business Insider (4/11) 
LinkedIn Twitter Facebook Google+ Email
FBR News
Need cloud resources for your research?
The NIH is testing a new funding mechanism for its extramural research community. The NIH Commons Credits Pilot will advance biomedical research in big data and cloud computing. Help shape the future of cloud computing in biomedical research by registering now for the 2017 award cycle. Learn more.
LinkedIn Twitter Facebook Google+ Email
Donate
For 35 years, FBR has advanced biomedical research for the sake of both human and animal health. We can't do our job without your support. Please give what you can. Together we will continue to make a difference.
LinkedIn Twitter Facebook Google+ Email
 
  
  
Change is a law, and no amount of pretending will alter that reality.
Dan Millman,
gymnast, writer and lecturer
LinkedIn Twitter Facebook Google+ Email
  
  
Learn more about FBR:
About FBR | Donate
About FBR
The Foundation for Biomedical Research (FBR) is the nation’s oldest and largest non-profit dedicated to improving human and animal health by promoting public understanding and support for biomedical research. Our mission is to educate people about the essential role animal research plays in the quest for medical advancements, treatments and cures for both people and animals.
Sign Up
SmartBrief offers 200+ newsletters
Subscriber Tools:
Contact Us:
Editor  -  Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information